Journal article
Total Biaya Terapi Insulin pada Kasus Diabetes Mellitus Tipe 2 Rawat Jalan di Kotamadya Denpasar
Luh Putu Febryana Larasanty I Gusti Ngurah Agung Dewantara Putra MADE ARY SARASMITA
Volume : 7 Nomor : 1 Published : 2017, March
Jurnal Manajemen dan Pelayanan Farmasi
Abstrak
Insulin is one of the drug therapy for type 2 diabetes patients. There are 4 types of insulin based on the onset of action, each type has it own cost and effectiveness. Has been a lot research about insulin effectiveness, however there was just few research reviewing about the total cost required for the insulin therapy. The purposes of this study is to determine of the total cost incurred for prescribed insulin therapy for type 2 diabetes outpatient in Denpasar municipality. This study was a descriptive study that conducted in March to June 2016 in General Hospital in Denpasar municipality. Research subject of this study was diabetic type 2 outpatient. Data of insulin therapy regimens and its costs obtained from patients' medical records, prescription data, administration sheet, patient therapy reports at the pharmacy as well as the social history of the patient. The total cost is calculated based on direct medical costs (physician services, laboratory tests, drugs and preparation cost of medicines and equipment), direct non-medical costs (administration fees and transport) and indirect non-medical costs (loss of salary / wages because they do not come to work). There were 8 branded name of insulin are prescribed for the diabetic patient, with it each percentage of use as follows: Apidra Solostar (12.50%), Humalog Mix (4.35%), Humalog Quickpen (3.80%), Humulin N (2.17%), Lantus Solostar (28.26%), Levemir (11.96%), Novomix (1.09%) and Novorapid (35.87%). Lowest total cost of prescribed insulin are Lantus Solostar (IDR 528.480,-) , while the highest are Humalog Mix (IDR 685.066,-). The average total cost of insulin therapy is IDR 565.474,-.